MEDLAB ANNOUNCES FAVOURABLE INTERIM READOUT OF NANABISâ„¢ REAL-WORLD EVIDENCE (RWE) MEDCARE STUDY
Medlab Clinical has obtained a New South Wales (NSW) Government grant for developing a proof-of-concept (PoC) NanoCelle Nasal RNA vaccine for Covid-19.
SYDNEY, Jan. 14, 2022 (GLOBE NEWSWIRE) -- Medlab Clinical Ltd (ASX:MDC) is pleased to announce in collaboration with Prof Pall Thordarson (Director of the UNSW RNA Institute, UNSW) and Prof Daniela Traini (NHMRC Investigator, Biomedical Sciences, Macquarie University and The Woolcock Institute of Medical Research) received a NSW Government grant to develop a Proof-of-Concept NanoCelle® Nasal RNA vaccine as part of Australia’s need to develop innovative infrastructure and manufacturing for the ongoing fight against COVID-19.